Joshua Taygerly

Joshua Taygerly is a seasoned professional in the field of medicinal chemistry, currently serving as VP and Head of Medicinal Chemistry at IDEAYA Biosciences since November 2019. His career includes progressive leadership roles at IDEAYA, where Joshua previously held positions as Senior Director and Director of Medicinal Chemistry. Prior to IDEAYA, Joshua was Associate Director at Nurix Therapeutics and held the position of Senior Research Scientist at Amgen. Additional experience includes working as a Research Scientist at Roche Pharmaceuticals and as a Research Associate at Tularik. Joshua Taygerly earned a Bachelor of Science degree from Stanford University and has further education from UC Irvine.